Cargando…
Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors
Oncolytic viral therapy has gained significant traction as cancer therapy over the past 2 decades. Oncolytic viruses are uniquely designed both to lyse tumor cells through their replication and to recruit immune responses against virally infected cells. Increasingly, investigators are leveraging thi...
Autores principales: | Pearl, Taylor M., Markert, James M., Cassady, Kevin A., Ghonime, Mohammed G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453942/ https://www.ncbi.nlm.nih.gov/pubmed/30997392 http://dx.doi.org/10.1016/j.omto.2019.03.001 |
Ejemplares similares
-
The Antiviral Apparatus: STING and Oncolytic Virus Restriction
por: Lee, Joel, et al.
Publicado: (2019) -
Chimeric HCMV/HSV-1 and Δγ(1)34.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory()()
por: Ghonime, Mohammed G., et al.
Publicado: (2017) -
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
por: Cassady, Kevin A., et al.
Publicado: (2016) -
Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
por: Ghonime, Mohammed G, et al.
Publicado: (2021) -
Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2012)